N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy

Summary

Patients who undergo urgent/emergency coronary angiography can not receive any preventive treatment of contrast induced nephropathy. We tested the hypothesis that Neutrophil gelatinase-associated lipocalin (NGAL), a new biomarker predictive for AKI, allows early and effective treatment of contrast induced nephropathy in patients with urgent/emergency coronary angiography

Timeline

Start

2014-01

Primary completion

2015-12

Completion

2017-12

Drugs

Indications